ALENTIS Trademark

Trademark Overview


On Monday, September 25, 2023, a trademark application was filed for ALENTIS with the United States Patent and Trademark Office. The USPTO has given the ALENTIS trademark a serial number of 98196287. The federal status of this trademark filing is REGISTERED as of Tuesday, September 10, 2024. This trademark is owned by Alentis Therapeutics AG. The ALENTIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, for the treatment of cancer, autoimmune diseases, and organ fibrosis; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer, autoimmune diseases, and organ fibrosis; biological preparations for medical and therapeutic use for the treatment of cancer, autoimmune diseases, and organ fibrosis; all the aforesaid goods not for ophthalmological use; biopharmaceutical products, namely, pharmaceutical preparations for cancer treatment; pharmaceutical preparations and substances for cancer treatment; pharmaceutical preparations and substances for cancer prevention
alentis

General Information


Serial Number98196287
Word MarkALENTIS
Filing DateMonday, September 25, 2023
Status700 - REGISTERED
Status DateTuesday, September 10, 2024
Registration Number7500787
Registration DateTuesday, September 10, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 25, 2024

Trademark Statements


Description of MarkThe mark consists of the literal element "Alentis" where the "A" is in uppercase and in the shape of a stylized triangle and is followed by "lentis" in all lowercase letters.
Goods and ServicesPharmaceutical products, for the treatment of cancer, autoimmune diseases, and organ fibrosis; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer, autoimmune diseases, and organ fibrosis; biological preparations for medical and therapeutic use for the treatment of cancer, autoimmune diseases, and organ fibrosis; all the aforesaid goods not for ophthalmological use; biopharmaceutical products, namely, pharmaceutical preparations for cancer treatment; pharmaceutical preparations and substances for cancer treatment; pharmaceutical preparations and substances for cancer prevention
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 10, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAlentis Therapeutics AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAllschwil 4123
CH

Party NameAlentis Therapeutics AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAllschwil 4123
CH

Party NameAlentis Therapeutics AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAllschwil 4123
CH

Trademark Events


Event DateEvent Description
Thursday, September 28, 2023NEW APPLICATION ENTERED
Tuesday, October 10, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, October 1, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, October 11, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, February 22, 2024ASSIGNED TO LIE
Thursday, February 22, 2024PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, May 16, 2024ASSIGNED TO EXAMINER
Friday, May 17, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 5, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 25, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 25, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 10, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, September 10, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED